{"libItems":[{"hasNotes":true,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Sulfasalazin"],"strengths":["0,5 g"]}],"order":0,"form":"Stikkpille"}],"treatmentType":"Brand","isSupplement":false,"nameOfBrand":"Salazopyrin","nameFormStrength":"Salazopyrin Stikkpille 0,5 g","medicationUsedFor":{"key":"3","value":"ALLERGIMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Mesalazin Enterodepottab 1200 mg","treatmentId":"24920624-1560-40b6-091f-08d89bc0e3e5"}],"medicationName":"Salazopyrin Stikkpille 0,5 g","treatmentId":"62555087-e1b1-456e-0920-08d89bc0e3e5","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Mesalazin Enterodepottab 1200 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"A07E","drugName":"Salazopyrin Stikkpille 0,5 g","refType":"Atc"},{"key":"ID_9C24A055-1012-44BC-98B3-40DE1B4857B7","drugName":"Salazopyrin Stikkpille 0,5 g","refType":"Atc"},{"key":"ID_CCAFCC09-D336-4074-B295-E719FD186B82","drugName":"Salazopyrin Stikkpille 0,5 g","refType":"Atc"}],"usage":"Treatment","atc":"A07EC01","drugId":"ID_CCAFCC09-D336-4074-B295-E719FD186B82","treatmentStop":"2020-12-08T22:07:18.2040699","prescriptionActions":["SendM1","ConfirmLib","Prescribe"],"id":"b3542f41-7c5e-4ea7-946c-08d89bc0e3e7","treatmentId":"62555087-e1b1-456e-0920-08d89bc0e3e5","treatmentStart":"2020-12-08T22:05:48","dssnText":"sss","actionStatus":"ActionRequired","externalUpdate":"Unchanged","approvalStatus":"Approved","resepts":[{"localReseptState":"Unsigned","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":true,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Mesalazin"],"strengths":["1200 mg"]}],"order":0,"form":"Enterodepottab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Mesalazin Enterodepottab 1200 mg","medicationUsedFor":{"key":"MOT BETENNELSE","value":"MOT BETENNELSE"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Salazopyrin Stikkpille 0,5 g","treatmentId":"62555087-e1b1-456e-0920-08d89bc0e3e5"}],"medicationName":"Mesalazin Enterodepottab 1200 mg","treatmentId":"24920624-1560-40b6-091f-08d89bc0e3e5","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Salazopyrin Stikkpille 0,5 g","isMarkedAsHandled":false}],"warningReferences":[{"key":"A07E","drugName":"Mesalazin Enterodepottab 1200 mg","refType":"Atc"},{"key":"ID_988BB7D9-651D-4F6C-AA52-99A024179367","drugName":"Mesalazin Enterodepottab 1200 mg","refType":"Atc"},{"key":"ID_34BDE0B2-CBE5-4D22-A55E-29849B26EE73","drugName":"Mesalazin Enterodepottab 1200 mg","refType":"Atc"}],"usage":"Treatment","atc":"A07EC02","drugId":"ID_34BDE0B2-CBE5-4D22-A55E-29849B26EE73","treatmentStop":"2020-12-25T00:00:00","prescriptionActions":["SendM1","ConfirmLib","Prescribe"],"id":"2f8570bd-2f61-4e7e-946a-08d89bc0e3e7","treatmentId":"24920624-1560-40b6-091f-08d89bc0e3e5","treatmentStart":"2020-12-08T00:00:00","dssnText":"3 tabletter morgen i 18 dager","actionStatus":"ActionRequired","externalUpdate":"Unchanged","approvalStatus":"Approved","resepts":[{"localReseptState":"Unsigned","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":true,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Empagliflozin"],"strengths":["10 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Empagliflozin Tab 10 mg","medicationUsedFor":{"key":"335","value":"MOT DIABETES"},"treatmentStatus":"Active","clinicalWarnings":[{"interactionReferences":[{"source":"Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci 2013; 345: 274-7.\n\n\n\n","url":"http://www.ncbi.nlm.nih.gov/pubmed/23531958"},{"source":"\nClore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009; 15: 469-74.\n\n\n","url":"http://www.ncbi.nlm.nih.gov/pubmed/19454391"}],"medicationATreatmentId":"01e73869-3030-4382-52c7-08d7b069975c","medicationB":"Depo-Medrol Inj væske, susp 40 mg/ml","medicationBTreatmentId":"0bf9f4c3-3555-471e-086c-08d8a2b389b2","clinicalConsequences":"Forverrelse av diabetes.","situationCriteria":"Gjelder kun ved systemisk behandling med glukokortikoider i farmakologiske doser; gjelder ikke ved substitusjonsbehandling eller lokalbehandling.","sourceType":"Indirekte data","isTreatmentMarkedAsHandled":false,"handlingOptions":"Monitorering: Pasienten bør følges opp med blodsukkermålinger og dosen av det antidibetiske midlet økes ved behov.\n","header":"~Legemiddelet integerer med Depo-Medrol Inj væske, susp 40 mg/ml.~","type":"SevereInteraction","interactionWarningType":"SevereInteraction","festId":"ID_812D4DAC-0948-4730-8317-9F8F00E4C87D","label":"~Interaksjon: moderat - ikke håndert~","warningText":"Depo-Medrol Inj væske, susp 40 mg/ml","isMarkedAsHandled":false}],"warningReferences":[{"key":"A10B","drugName":"Empagliflozin Tab 10 mg","refType":"Atc"},{"key":"ID_DA8CAC56-BA7D-4C16-B5B9-211B6BCD3652","drugName":"Empagliflozin Tab 10 mg","refType":"Atc"}],"usage":"Fixed","atc":"A10BK03","shortDose":{"key":"93","value":"1 daglig"},"drugId":"ID_DA8CAC56-BA7D-4C16-B5B9-211B6BCD3652","treatmentStop":"2020-12-08T21:51:53.0829822","prescriptionActions":["SendM1","SendM5","ConfirmLib","Prescribe"],"id":"4e6fea1f-3c9c-4de1-c236-08d8984c1e6b","treatmentId":"01e73869-3030-4382-52c7-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","dssnText":"fafafafafaf\nSvelges hel","actionStatus":"ActionRequired","externalUpdate":"Handled","approvalStatus":"Approved","resepts":[{"localReseptState":"Unsigned","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Romiplostim"],"strengths":["250 mikrog"]}],"order":0,"form":"Pulv til inj væske"}],"treatmentType":"Package","isSupplement":false,"nameOfBrand":"Nplate","nameFormStrength":"Nplate Pulv til inj væske 250 mikrog","medicationUsedFor":{"key":"1152","value":"TIL INJEKSJON"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"B02B","drugName":"Nplate Pulv til inj væske 250 mikrog","refType":"Atc"},{"key":"ID_5B68114C-EA16-420F-BA20-6719B49319A2","drugName":"Nplate Pulv til inj væske 250 mikrog","refType":"Atc"},{"key":"029811","drugName":"Nplate Pulv til inj væske 250 mikrog","refType":"Atc"}],"usage":"AsNeeded","atc":"B02BX04","drugId":"029811","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"7dfca18e-b7fa-4716-b7f4-08d7b0699760","treatmentId":"9285e555-b7c7-4f26-52bb-08d7b069975c","treatmentStart":"2019-09-11T00:00:00","dssnText":"LAR resept from FM","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Icatibant"],"strengths":["30 mg/1 sprøyte"]}],"order":0,"form":"Inj væske"}],"treatmentType":"Package","isSupplement":false,"nameOfBrand":"Firazyr","nameFormStrength":"Firazyr Inj væske 30 mg/sprøyte","medicationUsedFor":{"key":"1152","value":"TIL INJEKSJON"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"B06A","drugName":"Firazyr Inj væske 30 mg/sprøyte","refType":"Atc"},{"key":"ID_C42C10A6-059B-4A9C-AAD8-1B46688305FC","drugName":"Firazyr Inj væske 30 mg/sprøyte","refType":"Atc"},{"key":"146529","drugName":"Firazyr Inj væske 30 mg/sprøyte","refType":"Atc"}],"usage":"AsNeeded","atc":"B06AC02","drugId":"146529","prescriptionActions":["Stop","ConfirmLib","Change","AddResept","Prescribe"],"id":"8df8647a-0c99-408a-b7f6-08d7b0699760","treatmentId":"2d5524ee-852c-41c6-52bd-08d7b069975c","treatmentStart":"2019-05-27T00:00:00","dssnText":"LAR on Firazyr from FM","actionStatus":"Ready","externalUpdate":"Handled","approvalStatus":"Approved","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Molsidomin"],"strengths":["8 mg"]}],"order":0,"form":"DEPOTtab"}],"treatmentType":"Brand","isSupplement":false,"nameOfBrand":"Molsidomin","nameFormStrength":"Molsidomin DEPOTtab 8 mg","medicationUsedFor":{"key":"3","value":"ALLERGIMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Molsidomin DEPOTtab 8 mg","treatmentId":"58ef8054-16a9-4f70-0868-08d8a2b389b2"}],"medicationName":"Molsidomin DEPOTtab 8 mg","treatmentId":"c1ca603b-db4d-4109-0867-08d8a2b389b2","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Molsidomin DEPOTtab 8 mg","isMarkedAsHandled":false},{"label":"~Interaksjon: unknown - ikke håndert~","type":"InteractionInformationMissing","warningText":"Molsidomin DEPOTtab 8 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"C01D","drugName":"Molsidomin DEPOTtab 8 mg","refType":"Atc"},{"key":"ID_EB7FB0E3-8F41-404B-8CEE-CAD60A9CB61A","drugName":"Molsidomin DEPOTtab 8 mg","refType":"Atc"},{"key":"ID_AEDCECE8-33BE-41F2-890F-C2F2282582C1","drugName":"Molsidomin DEPOTtab 8 mg","refType":"Atc"}],"usage":"Fixed","atc":"C01DX12","drugId":"ID_AEDCECE8-33BE-41F2-890F-C2F2282582C1","prescriptionActions":["Stop","Renew","Change","Prescribe"],"id":"4b5b9939-8219-4f12-f3f4-08d8a2b389b4","treatmentId":"c1ca603b-db4d-4109-0867-08d8a2b389b2","treatmentStart":"2020-12-17T00:00:00","dssnText":"2 tabletter morgen daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"Recalled"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Molsidomin"],"strengths":["8 mg"]}],"order":0,"form":"DEPOTtab"}],"treatmentType":"Brand","isSupplement":false,"nameOfBrand":"Molsidomin","nameFormStrength":"Molsidomin DEPOTtab 8 mg","medicationUsedFor":{"key":"3","value":"ALLERGIMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Molsidomin DEPOTtab 8 mg","treatmentId":"c1ca603b-db4d-4109-0867-08d8a2b389b2"}],"medicationName":"Molsidomin DEPOTtab 8 mg","treatmentId":"58ef8054-16a9-4f70-0868-08d8a2b389b2","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Molsidomin DEPOTtab 8 mg","isMarkedAsHandled":false},{"label":"~Interaksjon: unknown - ikke håndert~","type":"InteractionInformationMissing","warningText":"Molsidomin DEPOTtab 8 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"C01D","drugName":"Molsidomin DEPOTtab 8 mg","refType":"Atc"},{"key":"ID_EB7FB0E3-8F41-404B-8CEE-CAD60A9CB61A","drugName":"Molsidomin DEPOTtab 8 mg","refType":"Atc"},{"key":"ID_AEDCECE8-33BE-41F2-890F-C2F2282582C1","drugName":"Molsidomin DEPOTtab 8 mg","refType":"Atc"}],"usage":"Fixed","atc":"C01DX12","drugId":"ID_AEDCECE8-33BE-41F2-890F-C2F2282582C1","prescriptionActions":["Stop","ConfirmUse","Renew","Change","Prescribe"],"id":"084a651f-0a12-4cc6-f3f5-08d8a2b389b4","treatmentId":"58ef8054-16a9-4f70-0868-08d8a2b389b2","treatmentStart":"2020-12-17T00:00:00","dssnText":"2 tabletter morgen daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"AvailableForDispatch"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Diklofenak"],"strengths":["3 %"]}],"order":0,"form":"Gel"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Diklofenak Gel 3 %","medicationUsedFor":{"key":"1382","value":"MOT KERATOSE"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Diklofenak Gel 3 %","treatmentId":"94f32229-88a8-4551-0869-08d8a2b389b2"},{"name":"Diklofenak Gel 3 %","treatmentId":"b4ed57cc-14da-4df3-086a-08d8a2b389b2"}],"medicationName":"Diklofenak Gel 3 %","treatmentId":"8e17d97e-cd9e-499e-0866-08d8a2b389b2","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Diklofenak Gel 3 %, Diklofenak Gel 3 %","isMarkedAsHandled":false}],"warningReferences":[{"key":"D11A","drugName":"Diklofenak Gel 3 %","refType":"Atc"},{"key":"ID_ADFA0741-6A46-4A90-8AAE-BC7DB18B27E1","drugName":"Diklofenak Gel 3 %","refType":"Atc"},{"key":"ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","drugName":"Diklofenak Gel 3 %","refType":"Atc"}],"usage":"Fixed","atc":"D11AX18","shortDose":{"key":"143","value":"1x2 Påsmøres"},"drugId":"ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","prescriptionActions":["Stop","Renew","Change","Prescribe"],"id":"910fc580-c231-474b-f3f3-08d8a2b389b4","treatmentId":"8e17d97e-cd9e-499e-0866-08d8a2b389b2","treatmentStart":"2020-12-17T00:00:00","dssnText":"1x2 Påsmøres","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"Recalled"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Diklofenak"],"strengths":["3 %"]}],"order":0,"form":"Gel"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Diklofenak Gel 3 %","medicationUsedFor":{"key":"1382","value":"MOT KERATOSE"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Diklofenak Gel 3 %","treatmentId":"8e17d97e-cd9e-499e-0866-08d8a2b389b2"},{"name":"Diklofenak Gel 3 %","treatmentId":"b4ed57cc-14da-4df3-086a-08d8a2b389b2"}],"medicationName":"Diklofenak Gel 3 %","treatmentId":"94f32229-88a8-4551-0869-08d8a2b389b2","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Diklofenak Gel 3 %, Diklofenak Gel 3 %","isMarkedAsHandled":false}],"warningReferences":[{"key":"D11A","drugName":"Diklofenak Gel 3 %","refType":"Atc"},{"key":"ID_ADFA0741-6A46-4A90-8AAE-BC7DB18B27E1","drugName":"Diklofenak Gel 3 %","refType":"Atc"},{"key":"ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","drugName":"Diklofenak Gel 3 %","refType":"Atc"}],"usage":"Fixed","atc":"D11AX18","shortDose":{"key":"143","value":"1x2 Påsmøres"},"drugId":"ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","prescriptionActions":["Stop","ConfirmUse","Renew","Change","Prescribe"],"id":"6ffb2013-5c58-4469-f3f6-08d8a2b389b4","treatmentId":"94f32229-88a8-4551-0869-08d8a2b389b2","treatmentStart":"2020-12-17T00:00:00","dssnText":"1x2 Påsmøres","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"AvailableForDispatch"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Diklofenak"],"strengths":["3 %"]}],"order":0,"form":"Gel"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Diklofenak Gel 3 %","medicationUsedFor":{"key":"1382","value":"MOT KERATOSE"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Diklofenak Gel 3 %","treatmentId":"8e17d97e-cd9e-499e-0866-08d8a2b389b2"},{"name":"Diklofenak Gel 3 %","treatmentId":"94f32229-88a8-4551-0869-08d8a2b389b2"}],"medicationName":"Diklofenak Gel 3 %","treatmentId":"b4ed57cc-14da-4df3-086a-08d8a2b389b2","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Diklofenak Gel 3 %, Diklofenak Gel 3 %","isMarkedAsHandled":false}],"warningReferences":[{"key":"D11A","drugName":"Diklofenak Gel 3 %","refType":"Atc"},{"key":"ID_ADFA0741-6A46-4A90-8AAE-BC7DB18B27E1","drugName":"Diklofenak Gel 3 %","refType":"Atc"},{"key":"ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","drugName":"Diklofenak Gel 3 %","refType":"Atc"}],"usage":"Fixed","atc":"D11AX18","shortDose":{"key":"143","value":"1x2 Påsmøres"},"drugId":"ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","prescriptionActions":["Stop","ConfirmUse","Renew","Change","Prescribe"],"id":"9de177ff-a194-4b20-f3f7-08d8a2b389b4","treatmentId":"b4ed57cc-14da-4df3-086a-08d8a2b389b2","treatmentStart":"2020-12-17T00:00:00","dssnText":"1x2 Påsmøres","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"AvailableForDispatch"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Tibolon"],"strengths":["2,5 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Brand","isSupplement":false,"nameOfBrand":"Livial","nameFormStrength":"Tibolon Tab 2,5 mg","medicationUsedFor":{"key":"235","value":"MOT BENSKJØRHET"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"G03C","drugName":"Tibolon Tab 2,5 mg","refType":"Atc"},{"key":"ID_1B9C848C-4166-4981-B6B9-CBB368209916","drugName":"Tibolon Tab 2,5 mg","refType":"Atc"},{"key":"ID_0C27CB3B-3E4E-4A0A-B34F-879EC55391A2","drugName":"Tibolon Tab 2,5 mg","refType":"Atc"}],"usage":"AsNeeded","atc":"G03CX01","shortDose":{"key":"93","value":"1 daglig"},"drugId":"ID_0C27CB3B-3E4E-4A0A-B34F-879EC55391A2","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"2d5ca65b-4e16-4c60-b7f9-08d7b0699760","treatmentId":"8f52e806-3ef8-416d-52c0-08d7b069975c","treatmentStart":"2019-05-27T00:00:00","dssnText":"1 tablett daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Metylprednisolon"],"strengths":["40 mg/1 ml"]}],"order":0,"form":"Inj væske, susp"}],"treatmentType":"Brand","isSupplement":false,"nameOfBrand":"Depo-Medrol","nameFormStrength":"Depo-Medrol Inj væske, susp 40 mg/ml","medicationUsedFor":{"key":"3","value":"ALLERGIMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[{"interactionReferences":[{"source":"Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci 2013; 345: 274-7.\n\n\n\n","url":"http://www.ncbi.nlm.nih.gov/pubmed/23531958"},{"source":"\nClore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009; 15: 469-74.\n\n\n","url":"http://www.ncbi.nlm.nih.gov/pubmed/19454391"}],"medicationATreatmentId":"0bf9f4c3-3555-471e-086c-08d8a2b389b2","medicationB":"Empagliflozin Tab 10 mg","medicationBTreatmentId":"01e73869-3030-4382-52c7-08d7b069975c","clinicalConsequences":"Forverrelse av diabetes.","situationCriteria":"Gjelder kun ved systemisk behandling med glukokortikoider i farmakologiske doser; gjelder ikke ved substitusjonsbehandling eller lokalbehandling.","sourceType":"Indirekte data","isTreatmentMarkedAsHandled":false,"handlingOptions":"Monitorering: Pasienten bør følges opp med blodsukkermålinger og dosen av det antidibetiske midlet økes ved behov.\n","header":"~Legemiddelet integerer med Empagliflozin Tab 10 mg.~","type":"SevereInteraction","interactionWarningType":"SevereInteraction","festId":"ID_812D4DAC-0948-4730-8317-9F8F00E4C87D","label":"~Interaksjon: moderat - ikke håndert~","warningText":"Empagliflozin Tab 10 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"H02A","drugName":"Depo-Medrol Inj væske, susp 40 mg/ml","refType":"Atc"},{"key":"ID_03523CCF-A67A-4C29-A0C7-E00E21E06371","drugName":"Depo-Medrol Inj væske, susp 40 mg/ml","refType":"Atc"},{"key":"ID_7DD83E06-8985-4037-ACDE-25B3FCE36F7F","drugName":"Depo-Medrol Inj væske, susp 40 mg/ml","refType":"Atc"}],"usage":"Fixed","atc":"H02AB04","drugId":"ID_7DD83E06-8985-4037-ACDE-25B3FCE36F7F","prescriptionActions":["Prescribe"],"id":"9b974e76-9b43-4034-f3f9-08d8a2b389b4","treatmentId":"0bf9f4c3-3555-471e-086c-08d8a2b389b2","treatmentStart":"2020-12-18T00:00:00","dssnText":"3 ml morgen i 28 dager","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"Recalled"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Para-aminosalisylsyre"],"strengths":["4 g"]}],"order":0,"form":"Enterogran"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Para-aminosalisylsyre Enterogran 4 g","medicationUsedFor":{"key":"820","value":"MOT TUBERKULOSE"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"J04A","drugName":"Para-aminosalisylsyre Enterogran 4 g","refType":"Atc"},{"key":"ID_9D3EF9A4-04D2-40DF-9BEB-AEF8D878691D","drugName":"Para-aminosalisylsyre Enterogran 4 g","refType":"Atc"},{"key":"ID_E3354E86-1A8A-4D62-B15A-DBBB7CF312C8","drugName":"Para-aminosalisylsyre Enterogran 4 g","refType":"Atc"}],"usage":"AsNeeded","atc":"J04AA01","drugId":"ID_E3354E86-1A8A-4D62-B15A-DBBB7CF312C8","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"b79ef8e0-c8ac-4ba3-b7f2-08d7b0699760","treatmentId":"381ecbf5-7f7f-4af7-52b9-08d7b069975c","treatmentStart":"2019-11-28T00:00:00","dssnText":"3 g morgen og 3 g ettermiddag daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":true,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Dibotermin alfa"],"strengths":["1,5 mg/1 ml"]}],"order":0,"form":"Sett til matriks til implantasjon"}],"treatmentType":"Package","isSupplement":false,"nameOfBrand":"InductOs","nameFormStrength":"InductOs Sett til matriks til implantasjon 1,5 mg/ml","medicationUsedFor":{"key":"15","value":"ASTMAMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"M05B","drugName":"InductOs Sett til matriks til implantasjon 1,5 mg/ml","refType":"Atc"},{"key":"ID_2C9C5623-38F6-4F93-9605-1491D884F9EE","drugName":"InductOs Sett til matriks til implantasjon 1,5 mg/ml","refType":"Atc"},{"key":"181720","drugName":"InductOs Sett til matriks til implantasjon 1,5 mg/ml","refType":"Atc"}],"usage":"Treatment","atc":"M05BC01","drugId":"181720","treatmentStop":"2020-12-08T00:00:00","prescriptionActions":["SendM1","SendM5","ConfirmLib","Prescribe"],"id":"514c02d5-2fdc-4494-946b-08d89bc0e3e7","treatmentId":"158833ff-5f65-4113-52be-08d7b069975c","treatmentStart":"2020-12-08T22:00:42","dssnText":"New from FM to test automatic lookups","actionStatus":"Ready","externalUpdate":"Unchanged","approvalStatus":"Approved","resepts":[{"localReseptState":"Unsigned","rfReseptState":"NotInRf"}],"diffPreviousValues":[{"field":"Amount","value":"1 "},{"field":"TotalPrescribed","value":"1"},{"field":"ReIterations","value":"0"},{"field":"PrescribedBy","value":"MAY JONES"}],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Paracetamol","Kodeinfosfathemihydrat"],"strengths":["500 mg","30 mg"]}],"order":0,"form":"Brusetab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","medicationUsedFor":{"key":"1060","value":"SMERTESTILLENDE"},"treatmentStatus":"Active","clinicalWarnings":[{"interactionReferences":[{"source":"Baxter K (utg.) Stockley's Drug interactions (9 utg.) London: The Pharmaceutical Press, 2010: 106."},{"source":"Obayashi K et al. Risk of falling and hypnotic drugs: retrospective study of inpatients. Drugs R D 2013; 13: 159-64.","url":"http://www.ncbi.nlm.nih.gov/pubmed/?term=23760758"}],"medicationATreatmentId":"c2758d7d-d1f3-40f1-52bf-08d7b069975c","medicationB":"Zopiklon Tab 5 mg","medicationBTreatmentId":"1b89b800-66f5-4a86-52c4-08d7b069975c","clinicalConsequences":"Økt sedasjon/CNS-depresjon.","situationCriteria":"Gjelder ikke ved sporadisk kombinasjonsbruk. Merk for øvrig informasjon under \"Monitorering\".","sourceType":"Indirekte data","isTreatmentMarkedAsHandled":false,"handlingOptions":"Monitorering: Det bør vurderes særskilt om en kombinasjon av z-hypnotika og opioider er rasjonell, ikke minst hos eldre og skrøpelige pasienter og hos pasienter med ikke-maligne smerter.\n","header":"~Legemiddelet integerer med Zopiklon Tab 5 mg.~","type":"SevereInteraction","interactionWarningType":"SevereInteraction","festId":"ID_822C0E86-FA5F-45CB-84CF-A30200ECC86A","label":"~Interaksjon: moderat - ikke håndert~","warningText":"Zopiklon Tab 5 mg","isMarkedAsHandled":false},{"interactionReferences":[{"source":"Baxter K (utg.) Stockley's Drug interactions (9 utg.) London: The Pharmaceutical Press, 2010: 106."},{"source":"Obayashi K et al. Risk of falling and hypnotic drugs: retrospective study of inpatients. Drugs R D 2013; 13: 159-64.","url":"http://www.ncbi.nlm.nih.gov/pubmed/?term=23760758"}],"medicationATreatmentId":"c2758d7d-d1f3-40f1-52bf-08d7b069975c","medicationB":"Zopiklon Tab 7,5 mg","medicationBTreatmentId":"fea26cd8-4403-430d-52b8-08d7b069975c","clinicalConsequences":"Økt sedasjon/CNS-depresjon.","situationCriteria":"Gjelder ikke ved sporadisk kombinasjonsbruk. Merk for øvrig informasjon under \"Monitorering\".","sourceType":"Indirekte data","isTreatmentMarkedAsHandled":false,"handlingOptions":"Monitorering: Det bør vurderes særskilt om en kombinasjon av z-hypnotika og opioider er rasjonell, ikke minst hos eldre og skrøpelige pasienter og hos pasienter med ikke-maligne smerter.\n","header":"~Legemiddelet integerer med Zopiklon Tab 7,5 mg.~","type":"SevereInteraction","interactionWarningType":"SevereInteraction","festId":"ID_822C0E86-FA5F-45CB-84CF-A30200ECC86A","label":"~Interaksjon: moderat - ikke håndert~","warningText":"Zopiklon Tab 7,5 mg","isMarkedAsHandled":false},{"medications":[{"name":"Paracetamol Gran 250 mg","treatmentId":"0c058f00-1073-42ff-52b5-08d7b069975c"}],"medicationName":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","treatmentId":"c2758d7d-d1f3-40f1-52bf-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Paracetamol Gran 250 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N02A","drugName":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","refType":"Atc"},{"key":"ID_F032828A-8E8F-45FC-B2D8-3F0EBCDB5DBC","drugName":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","refType":"Atc"},{"key":"ID_7B4E2DBB-C8AE-4A8D-B3EF-E380C5D8C3D9","drugName":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","refType":"Atc"},{"key":"ID_FBDE3B5E-9D7D-48C9-A378-F833A79DFC62","drugName":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","refType":"Atc"}],"usage":"Fixed","atc":"N02AJ06","shortDose":{"key":"234","value":"1-2 inntil x4"},"drugId":"ID_FBDE3B5E-9D7D-48C9-A378-F833A79DFC62","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"3dc64fed-fcce-470a-b7f8-08d7b0699760","treatmentId":"c2758d7d-d1f3-40f1-52bf-08d7b069975c","treatmentStart":"2019-05-27T00:00:00","dssnText":"1-2 tabletter inntil 4 ganger daglig\nOppløses i 1/2 glass vann og drikkes","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Fenazon","Koffein"],"strengths":["1 g","100 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Fenazon/Koffein Tab 1 g/100 mg","medicationUsedFor":{"key":"1184","value":"MOT HODEPINE"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Paracetamol Gran 250 mg","treatmentId":"0c058f00-1073-42ff-52b5-08d7b069975c"}],"medicationName":"Fenazon/Koffein Tab 1 g/100 mg","treatmentId":"27b194fb-790b-473a-086b-08d8a2b389b2","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Paracetamol Gran 250 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N02B","drugName":"Fenazon/Koffein Tab 1 g/100 mg","refType":"Atc"},{"key":"ID_4A943FA6-FFC3-4921-8D67-AFB1D7F95C87","drugName":"Fenazon/Koffein Tab 1 g/100 mg","refType":"Atc"},{"key":"ID_1D6E8CFB-CC28-4E1C-8E5A-E0D562871A8F","drugName":"Fenazon/Koffein Tab 1 g/100 mg","refType":"Atc"},{"key":"ID_CF071068-DF45-4F64-A272-857E4EF0CB78","drugName":"Fenazon/Koffein Tab 1 g/100 mg","refType":"Atc"}],"usage":"Fixed","atc":"N02BB51","shortDose":{"key":"79","value":"1 inntil x3"},"drugId":"ID_CF071068-DF45-4F64-A272-857E4EF0CB78","prescriptionActions":["Prescribe"],"id":"a2dfee97-5808-468a-f3f8-08d8a2b389b4","treatmentId":"27b194fb-790b-473a-086b-08d8a2b389b2","treatmentStart":"2020-12-17T00:00:00","dssnText":"1 inntil x3","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"Recalled"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Paracetamol"],"strengths":["250 mg"]}],"order":0,"form":"Gran"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Paracetamol Gran 250 mg","medicationUsedFor":{"key":"20","value":"AVFØRENDE MIDDEL"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Fenazon/Koffein Tab 1 g/100 mg","treatmentId":"27b194fb-790b-473a-086b-08d8a2b389b2"}],"medicationName":"Paracetamol Gran 250 mg","treatmentId":"0c058f00-1073-42ff-52b5-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Fenazon/Koffein Tab 1 g/100 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N02B","drugName":"Paracetamol Gran 250 mg","refType":"Atc"},{"key":"ID_F032828A-8E8F-45FC-B2D8-3F0EBCDB5DBC","drugName":"Paracetamol Gran 250 mg","refType":"Atc"},{"key":"ID_86EC1402-96E6-4DC5-AB9A-434EC440575F","drugName":"Paracetamol Gran 250 mg","refType":"Atc"}],"usage":"Fixed","atc":"N02BE01","drugId":"ID_86EC1402-96E6-4DC5-AB9A-434EC440575F","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"41042767-cc64-4f2a-b7ee-08d7b0699760","treatmentId":"0c058f00-1073-42ff-52b5-08d7b069975c","treatmentStart":"2020-02-04T00:00:00","dssnText":"Første behandlingsdag 21.2.2020: 2 pose morgen, 3 pose formiddag og 2 pose ettermiddag daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Naratriptan"],"strengths":["2,5 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Naratriptan Tab 2,5 mg","medicationUsedFor":{"key":"610","value":"MOT MIGRENE"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"N02C","drugName":"Naratriptan Tab 2,5 mg","refType":"Atc"},{"key":"ID_222B19E7-6E54-46B7-8573-278E038881B2","drugName":"Naratriptan Tab 2,5 mg","refType":"Atc"},{"key":"ID_3B539428-FD9C-4998-AFBD-BA2911019097","drugName":"Naratriptan Tab 2,5 mg","refType":"Atc"}],"usage":"Fixed","atc":"N02CC02","drugId":"ID_3B539428-FD9C-4998-AFBD-BA2911019097","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"5425c90b-35fb-426e-b7fe-08d7b0699760","treatmentId":"06bfaa80-f770-42f9-52c5-08d7b069975c","treatmentStart":"2019-05-22T00:00:00","dssnText":"This is created in fastlege","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Pramipeksol"],"strengths":["1,05 mg"]}],"order":0,"form":"DEPOTtab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Pramipeksol DEPOTtab 1,05 mg","medicationUsedFor":{"key":"640","value":"MOT PARKINSONISME"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Safinamid Tab 50 mg","treatmentId":"c72d2323-0778-410f-52b6-08d7b069975c"},{"name":"Safinamid Tab 50 mg","treatmentId":"8487ea88-9149-4e6c-52ba-08d7b069975c"}],"medicationName":"Pramipeksol DEPOTtab 1,05 mg","treatmentId":"63689934-8e3c-4d56-52c3-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Safinamid Tab 50 mg, Safinamid Tab 50 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N04B","drugName":"Pramipeksol DEPOTtab 1,05 mg","refType":"Atc"},{"key":"ID_94D39969-4EBB-4A56-B934-6B4F1C1129DE","drugName":"Pramipeksol DEPOTtab 1,05 mg","refType":"Atc"},{"key":"ID_5D3FBCE5-26DB-41C0-AFC3-21B0E68F4914","drugName":"Pramipeksol DEPOTtab 1,05 mg","refType":"Atc"}],"usage":"Fixed","atc":"N04BC05","shortDose":{"key":"21","value":"0+0+1"},"drugId":"ID_5D3FBCE5-26DB-41C0-AFC3-21B0E68F4914","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"d5de5765-4efd-4253-b7fc-08d7b0699760","treatmentId":"63689934-8e3c-4d56-52c3-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","dssnText":"1 tablett kveld\nSvelges hel med 1 glass vann","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Safinamid"],"strengths":["50 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Safinamid Tab 50 mg","medicationUsedFor":{"key":"5","value":"ANTIMALARIAMIDDEL"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Safinamid Tab 50 mg","treatmentId":"8487ea88-9149-4e6c-52ba-08d7b069975c"},{"name":"Pramipeksol DEPOTtab 1,05 mg","treatmentId":"63689934-8e3c-4d56-52c3-08d7b069975c"}],"medicationName":"Safinamid Tab 50 mg","treatmentId":"c72d2323-0778-410f-52b6-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Safinamid Tab 50 mg, Pramipeksol DEPOTtab 1,05 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N04B","drugName":"Safinamid Tab 50 mg","refType":"Atc"},{"key":"ID_C435FF73-131E-40C3-9801-F2F4EF1C6D93","drugName":"Safinamid Tab 50 mg","refType":"Atc"},{"key":"ID_E4BB393F-E8D2-46D6-A7F9-9C07F595BAD2","drugName":"Safinamid Tab 50 mg","refType":"Atc"}],"usage":"Fixed","atc":"N04BD03","shortDose":{"key":"93","value":"1 daglig"},"drugId":"ID_E4BB393F-E8D2-46D6-A7F9-9C07F595BAD2","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"caad28e9-09ec-4441-b7ef-08d7b0699760","treatmentId":"c72d2323-0778-410f-52b6-08d7b069975c","treatmentStart":"2020-02-04T00:00:00","dssnText":"1 tablett daglig adding forholdsregele\nadding forholdsregele","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Safinamid"],"strengths":["50 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Safinamid Tab 50 mg","medicationUsedFor":{"key":"5","value":"ANTIMALARIAMIDDEL"},"treatmentStatus":"Active","clinicalWarnings":[{"medications":[{"name":"Safinamid Tab 50 mg","treatmentId":"c72d2323-0778-410f-52b6-08d7b069975c"},{"name":"Pramipeksol DEPOTtab 1,05 mg","treatmentId":"63689934-8e3c-4d56-52c3-08d7b069975c"}],"medicationName":"Safinamid Tab 50 mg","treatmentId":"8487ea88-9149-4e6c-52ba-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Safinamid Tab 50 mg, Pramipeksol DEPOTtab 1,05 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N04B","drugName":"Safinamid Tab 50 mg","refType":"Atc"},{"key":"ID_C435FF73-131E-40C3-9801-F2F4EF1C6D93","drugName":"Safinamid Tab 50 mg","refType":"Atc"},{"key":"ID_E4BB393F-E8D2-46D6-A7F9-9C07F595BAD2","drugName":"Safinamid Tab 50 mg","refType":"Atc"}],"usage":"Fixed","atc":"N04BD03","shortDose":{"key":"266","value":"2 daglig"},"drugId":"ID_E4BB393F-E8D2-46D6-A7F9-9C07F595BAD2","prescriptionActions":["Stop","ConfirmUse","Renew","Change","Prescribe"],"id":"aaa648da-7d78-4587-b7f3-08d7b0699760","treatmentId":"8487ea88-9149-4e6c-52ba-08d7b069975c","treatmentStart":"2019-05-28T00:00:00","dssnText":"2 tabletter daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"Recalled"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":true,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Zopiklon"],"strengths":["5 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Zopiklon Tab 5 mg","medicationUsedFor":{"key":"140","value":"INNSOVNINGSMIDDEL"},"treatmentStatus":"Active","clinicalWarnings":[{"interactionReferences":[{"source":"Baxter K (utg.) Stockley's Drug interactions (9 utg.) London: The Pharmaceutical Press, 2010: 106."},{"source":"Obayashi K et al. Risk of falling and hypnotic drugs: retrospective study of inpatients. Drugs R D 2013; 13: 159-64.","url":"http://www.ncbi.nlm.nih.gov/pubmed/?term=23760758"}],"medicationATreatmentId":"1b89b800-66f5-4a86-52c4-08d7b069975c","medicationB":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","medicationBTreatmentId":"c2758d7d-d1f3-40f1-52bf-08d7b069975c","clinicalConsequences":"Økt sedasjon/CNS-depresjon.","situationCriteria":"Gjelder ikke ved sporadisk kombinasjonsbruk. Merk for øvrig informasjon under \"Monitorering\".","sourceType":"Indirekte data","isTreatmentMarkedAsHandled":false,"handlingOptions":"Monitorering: Det bør vurderes særskilt om en kombinasjon av z-hypnotika og opioider er rasjonell, ikke minst hos eldre og skrøpelige pasienter og hos pasienter med ikke-maligne smerter.\n","header":"~Legemiddelet integerer med Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg.~","type":"SevereInteraction","interactionWarningType":"SevereInteraction","festId":"ID_822C0E86-FA5F-45CB-84CF-A30200ECC86A","label":"~Interaksjon: moderat - ikke håndert~","warningText":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","isMarkedAsHandled":false},{"medications":[{"name":"Zopiklon Tab 7,5 mg","treatmentId":"fea26cd8-4403-430d-52b8-08d7b069975c"}],"medicationName":"Zopiklon Tab 5 mg","treatmentId":"1b89b800-66f5-4a86-52c4-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Zopiklon Tab 7,5 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N05C","drugName":"Zopiklon Tab 5 mg","refType":"Atc"},{"key":"ID_8B254174-7197-4AF9-8A78-739A805012BE","drugName":"Zopiklon Tab 5 mg","refType":"Atc"},{"key":"ID_ADCA79E6-2720-48A1-AD1C-30421C2EE12E","drugName":"Zopiklon Tab 5 mg","refType":"Atc"}],"usage":"Fixed","atc":"N05CF01","shortDose":{"key":"2","value":"1 ved sengetid"},"drugId":"ID_ADCA79E6-2720-48A1-AD1C-30421C2EE12E","prescriptionActions":["Prescribe"],"id":"79403b3d-55ac-4c11-b7fd-08d7b0699760","treatmentId":"1b89b800-66f5-4a86-52c4-08d7b069975c","treatmentStart":"2019-06-07T00:00:00","dssnText":"1 tablett ved sengetid","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"Recalled"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Zopiklon"],"strengths":["7,5 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Zopiklon Tab 7,5 mg","medicationUsedFor":{"key":"1197","value":"VED SØVNVANSKER"},"treatmentStatus":"Active","clinicalWarnings":[{"interactionReferences":[{"source":"Baxter K (utg.) Stockley's Drug interactions (9 utg.) London: The Pharmaceutical Press, 2010: 106."},{"source":"Obayashi K et al. Risk of falling and hypnotic drugs: retrospective study of inpatients. Drugs R D 2013; 13: 159-64.","url":"http://www.ncbi.nlm.nih.gov/pubmed/?term=23760758"}],"medicationATreatmentId":"fea26cd8-4403-430d-52b8-08d7b069975c","medicationB":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","medicationBTreatmentId":"c2758d7d-d1f3-40f1-52bf-08d7b069975c","clinicalConsequences":"Økt sedasjon/CNS-depresjon.","situationCriteria":"Gjelder ikke ved sporadisk kombinasjonsbruk. Merk for øvrig informasjon under \"Monitorering\".","sourceType":"Indirekte data","isTreatmentMarkedAsHandled":false,"handlingOptions":"Monitorering: Det bør vurderes særskilt om en kombinasjon av z-hypnotika og opioider er rasjonell, ikke minst hos eldre og skrøpelige pasienter og hos pasienter med ikke-maligne smerter.\n","header":"~Legemiddelet integerer med Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg.~","type":"SevereInteraction","interactionWarningType":"SevereInteraction","festId":"ID_822C0E86-FA5F-45CB-84CF-A30200ECC86A","label":"~Interaksjon: moderat - ikke håndert~","warningText":"Paracetamol/Kodeinfosfathemihydrat Brusetab 500 mg/30 mg","isMarkedAsHandled":false},{"medications":[{"name":"Zopiklon Tab 5 mg","treatmentId":"1b89b800-66f5-4a86-52c4-08d7b069975c"}],"medicationName":"Zopiklon Tab 7,5 mg","treatmentId":"fea26cd8-4403-430d-52b8-08d7b069975c","label":"~Dobbeltforskrivning - ikke håndert~","type":"DoubleMedication","warningText":"Zopiklon Tab 5 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"N05C","drugName":"Zopiklon Tab 7,5 mg","refType":"Atc"},{"key":"ID_8B254174-7197-4AF9-8A78-739A805012BE","drugName":"Zopiklon Tab 7,5 mg","refType":"Atc"},{"key":"ID_0D1BA935-A487-438D-834F-A505F83FF11E","drugName":"Zopiklon Tab 7,5 mg","refType":"Atc"}],"usage":"Fixed","atc":"N05CF01","drugId":"ID_0D1BA935-A487-438D-834F-A505F83FF11E","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"8bd54b4e-a181-403f-b7f1-08d7b0699760","treatmentId":"fea26cd8-4403-430d-52b8-08d7b069975c","treatmentStart":"2020-02-06T00:00:00","dssnText":"2 tabletter formiddag daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Atomoksetin"],"strengths":["25 mg"]}],"order":0,"form":"Kaps"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Atomoksetin Kaps 25 mg","medicationUsedFor":{"key":"515","value":"MOT HYPERAKTIVITET"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"N06B","drugName":"Atomoksetin Kaps 25 mg","refType":"Atc"},{"key":"ID_C6B0601C-B7F9-49F5-B977-01717103A917","drugName":"Atomoksetin Kaps 25 mg","refType":"Atc"},{"key":"ID_6BA2C59E-FD0B-4C37-A090-FC6C3FAE14CB","drugName":"Atomoksetin Kaps 25 mg","refType":"Atc"}],"usage":"Fixed","atc":"N06BA09","drugId":"ID_6BA2C59E-FD0B-4C37-A090-FC6C3FAE14CB","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"b2c81b22-bd16-42d2-b802-08d7b0699760","treatmentId":"a11d28ad-e178-4cda-52c9-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","dssnText":"1 kapsel morgen daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Tinidazol"],"strengths":["500 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Brand","isSupplement":false,"nameOfBrand":"Fasigyn","nameFormStrength":"Fasigyn Tab 500 mg","medicationUsedFor":{"key":"3","value":"ALLERGIMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[{"label":"~Interaksjon: unknown - ikke håndert~","type":"InteractionInformationMissing","warningText":"Fasigyn Tab 500 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"P01A","drugName":"Fasigyn Tab 500 mg","refType":"Atc"},{"key":"ID_570BFB79-FE85-48C6-96DC-23F33E535B5F","drugName":"Fasigyn Tab 500 mg","refType":"Atc"},{"key":"ID_3AEC1617-F201-4176-9F4F-665E62A8664A","drugName":"Fasigyn Tab 500 mg","refType":"Atc"}],"usage":"Fixed","atc":"P01AB02","drugId":"ID_3AEC1617-F201-4176-9F4F-665E62A8664A","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"0cc69277-c4c5-4c01-b7f0-08d7b0699760","treatmentId":"edf5687a-29c9-4985-52b7-08d7b069975c","treatmentStart":"2019-11-28T00:00:00","dssnText":"1 tablett morgen daglig","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Meflokin"],"strengths":["250 mg"]}],"order":0,"form":"Tab"}],"treatmentType":"Generic","isSupplement":false,"nameOfBrand":"","nameFormStrength":"Meflokin Tab 250 mg","medicationUsedFor":{"key":"591","value":"MOT MALARIA"},"treatmentStatus":"Active","clinicalWarnings":[],"warningReferences":[{"key":"P01B","drugName":"Meflokin Tab 250 mg","refType":"Atc"},{"key":"ID_22EB15FE-F197-4042-9AFB-E0CA1630FF82","drugName":"Meflokin Tab 250 mg","refType":"Atc"},{"key":"ID_736D80CE-C0B4-434F-B614-2ECF7FA978D1","drugName":"Meflokin Tab 250 mg","refType":"Atc"}],"usage":"Fixed","atc":"P01BC02","drugId":"ID_736D80CE-C0B4-434F-B614-2ECF7FA978D1","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"0711e174-3fc5-4604-b7ff-08d7b0699760","treatmentId":"9f605c92-6f97-4286-52c6-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","dssnText":"This is created in hospital","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false},{"hasNotes":false,"drugs":[{"ingredientNamesAndStrengths":[{"ingredientNames":["Amylmetakresol","2,4-Diklorbenzylalkohol"],"strengths":["0,6 mg","1,2 mg"]}],"order":0,"form":"Sugetab"}],"treatmentType":"Package","isSupplement":false,"nameOfBrand":"Solvivo","nameFormStrength":"Solvivo Sugetab med honning- og sitronsmak 0,6 mg/1,2 mg","medicationUsedFor":{"key":"3","value":"ALLERGIMEDISIN"},"treatmentStatus":"Active","clinicalWarnings":[{"label":"~Interaksjon: unknown - ikke håndert~","type":"InteractionInformationMissing","warningText":"Solvivo Sugetab med honning- og sitronsmak 0,6 mg/1,2 mg","isMarkedAsHandled":false}],"warningReferences":[{"key":"R02A","drugName":"Solvivo Sugetab med honning- og sitronsmak 0,6 mg/1,2 mg","refType":"Atc"},{"key":"ID_3585498D-E455-4F87-84EA-67A750D76BAE","drugName":"Solvivo Sugetab med honning- og sitronsmak 0,6 mg/1,2 mg","refType":"Atc"},{"key":"ID_622D3437-86D7-4208-8A65-4F4712746D96","drugName":"Solvivo Sugetab med honning- og sitronsmak 0,6 mg/1,2 mg","refType":"Atc"},{"key":"597538","drugName":"Solvivo Sugetab med honning- og sitronsmak 0,6 mg/1,2 mg","refType":"Atc"}],"usage":"AsNeeded","atc":"R02AA03","drugId":"597538","prescriptionActions":["Stop","ConfirmUse","Change","AddResept","Prescribe"],"id":"87ce9ed5-3092-4408-b7f5-08d7b0699760","treatmentId":"f7dbc70a-eb8d-4996-52bc-08d7b069975c","treatmentStart":"2019-06-05T00:00:00","dssnText":"LAR on 'Solvivo' from FM","actionStatus":"ActionRequired","externalUpdate":"New","approvalStatus":"Empty","resepts":[{"localReseptState":"None","rfReseptState":"NotInRf"}],"diffPreviousValues":[],"hasRfError":false}],"fibItems":[{"productCode":"503","productName":"Forbruksmateriell til laryngektomerte","notes":"","validUntil":"2020-05-14T00:00:00","hasNotes":false,"localReseptState":"None","rfReseptState":"NotInRf","refundApplication":"C503","prescriptionActions":["Change","AddResept","Prescribe"],"id":"6def35c1-cd94-405c-b7fa-08d7b0699760","treatmentId":"a87c54a5-ca52-454e-52c1-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","actionStatus":"Active","treatmentStatus":"Active","externalUpdate":"New","approvalStatus":"Empty","diffPreviousValues":[],"hasRfError":false},{"productCode":"507","productName":"Forbruksmateriell til lungesyke","notes":"","validUntil":"2020-05-23T00:00:00","hasNotes":false,"localReseptState":"None","rfReseptState":"NotInRf","refundApplication":"C507","prescriptionActions":["Change","AddResept","Prescribe"],"id":"163e8f93-6646-4f69-b7fb-08d7b0699760","treatmentId":"06d92c9a-6f14-4df6-52c2-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","actionStatus":"Active","treatmentStatus":"Active","externalUpdate":"New","approvalStatus":"Empty","diffPreviousValues":[],"hasRfError":false}],"nibItems":[{"productCode":"603","productName":"Næringsmidler ved Fenylketonuri (Føllings sykdom)","validUntil":"2020-05-23T00:00:00","hasNotes":false,"localReseptState":"None","rfReseptState":"NotInRf","refundApplication":"C603","prescriptionActions":["Change","AddResept","Prescribe"],"id":"0c91f731-46b3-460e-b801-08d7b0699760","treatmentId":"78eb9216-6ac5-41f9-52c8-08d7b069975c","treatmentStart":"2019-06-03T00:00:00","actionStatus":"Active","treatmentStatus":"Active","externalUpdate":"New","approvalStatus":"Empty","diffPreviousValues":[],"hasRfError":false}],"vaccines":[],"vibInformation":{"vibStatus":"ActionRequired","messagesToSign":{"new":0,"renewed":0,"changed":0,"stopped":1,"removed":0,"recalled":0,"registration":0},"actionRequired":{"treatments":8,"nutritions":0,"consumables":0,"vaccines":0,"allergies":0,"warnings":17},"previousLibItems":["ID_7DD83E06-8985-4037-ACDE-25B3FCE36F7F","ID_CF071068-DF45-4F64-A272-857E4EF0CB78","ID_25B41E33-9459-42E3-A7D8-71DD3DFAEAFF","ID_AEDCECE8-33BE-41F2-890F-C2F2282582C1","ID_CCAFCC09-D336-4074-B295-E719FD186B82","ID_34BDE0B2-CBE5-4D22-A55E-29849B26EE73","ID_6BA2C59E-FD0B-4C37-A090-FC6C3FAE14CB","ID_DA8CAC56-BA7D-4C16-B5B9-211B6BCD3652","ID_736D80CE-C0B4-434F-B614-2ECF7FA978D1","ID_3B539428-FD9C-4998-AFBD-BA2911019097","ID_ADCA79E6-2720-48A1-AD1C-30421C2EE12E","ID_5D3FBCE5-26DB-41C0-AFC3-21B0E68F4914","ID_0C27CB3B-3E4E-4A0A-B34F-879EC55391A2","ID_FBDE3B5E-9D7D-48C9-A378-F833A79DFC62","181720","146529","597538","029811","ID_E4BB393F-E8D2-46D6-A7F9-9C07F595BAD2","ID_E3354E86-1A8A-4D62-B15A-DBBB7CF312C8","ID_0D1BA935-A487-438D-834F-A505F83FF11E","ID_3AEC1617-F201-4176-9F4F-665E62A8664A","ID_86EC1402-96E6-4DC5-AB9A-434EC440575F"]}}